Teladoc Health, Inc. (TDOC)
The Gross Law Firm notifies investors that a class action has commenced in the United States District Court for the Southern District of New York on behalf of shareholders of Teladoc Health, Inc. (TDOC) who purchased shares between October 28, 2021 and April 27, 2022.
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that:
(i) increased competition, among other factors, was negatively impacting TDOC’s BetterHelp and chronic care businesses; (ii) accordingly, the growth of those businesses was less sustainable than Defendants had led investors to believe; (iii) as a result, TDOC’s revenue and adjusted EBITDA projections for FY 2022 were unrealistic; (iv) as a result of all the foregoing, TDOC would be forced to recognize a significant non-cash goodwill impairment charge; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until August 5, 2022 to request that the court appoint them lead plaintiff.
To receive more information, please fill out the form.
Teladoc Health, Inc. Class Action Lawsuit
Teladoc Health, Inc. Lawsuit
TDOC Class Action Lawsuit
Teladoc Health, Inc. (TDOC) Class Action Lawsuit